Co-Diagnostics Inc (CODX)
1.16
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
1.16
0.00 (0.00%)
After-Hours: 17:28
Co-Diagnostics Gross Profit Margin (Quarterly): 16.52% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.52% |
| September 30, 2023 | 89.59% |
| June 30, 2023 | -132.1% |
| March 31, 2023 | 16.57% |
| December 31, 2022 | 63.20% |
| September 30, 2022 | 84.93% |
| June 30, 2022 | 81.78% |
| March 31, 2022 | 85.54% |
| December 31, 2021 | 87.81% |
| September 30, 2021 | 89.00% |
| June 30, 2021 | 90.85% |
| March 31, 2021 | 83.66% |
| December 31, 2020 | 84.11% |
| September 30, 2020 | 73.32% |
| Date | Value |
|---|---|
| June 30, 2020 | 65.29% |
| March 31, 2020 | 68.89% |
| December 31, 2019 | 51.36% |
| September 30, 2019 | 50.85% |
| June 30, 2019 | 36.97% |
| March 31, 2019 | 86.71% |
| December 31, 2018 | 13.23% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 87.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-132.1%
Minimum
Jun 2023
90.85%
Maximum
Jun 2021
57.27%
Average
73.32%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
| PAVmed Inc | -53.57% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.36% |
| Return on Assets | -31.72% |
| Return on Invested Capital | -34.36% |
| Profit Margin (Quarterly) | -412.8% |
| Operating Margin (Quarterly) | -332.6% |
| Return on Net Operating Assets | -80.25% |